Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
5
×
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
drugs
texas blog main
bristol-myers squibb
celgene
eli lilly
fda
genentech
gilead sciences
intercept pharmaceuticals
johnson & johnson
merck
nonalcoholic steatohepatitis
obeticholic acid
What
known
5
×
drug
new
approved
bio
disease
fatty
led
liver
medicine
nash
roundup
adapt
biopharma
cells
cellular
changes
cholesterol
companies
congress
congressional
crispr
data
digital
drugs
epidemic
executives
expensive
faces
fda
feud
financial
foe
frenzied
goes
group
growing
healthcare
hint
horizon
Language
unset
Current search:
known
×
" new york blog main "
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More